Stock Ratings / Health Care / SMTI / options

ZJYL (36) INGN (36) AVR (23) AGPU (44) ⌘ Pro Terminal →

Sanara MedTech Inc. (SMTI) Options Positioning, Max Pain & Unusual Sweeps

Q: What is SMTI's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for SMTI.

$32.92 +0.11% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $32.86

Sanara MedTech Inc. (SMTI) carries a Roarable Rating of D+ (Sell) with 55/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $302.4M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on SMTI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is SMTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Sanara MedTech Inc. (NASDAQ: SMTI) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 55/100 at a spot price of $32.92 (+0.11% 1D, market cap $302.4M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 14/20. Across 1016 tracked Health Care issuers, SMTI ranks #232 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does SMTI compare to ZJYL and INGN in the Health Care sector?

▼

Within the Health Care sector (Industrial Specialties), SMTI carries a Roarable D+ (55/100 RQD), trailing P/E of 8.1x, gross margin of 92.7%, and ROIC of 16.3%. By comparison, ZJYL (JIN MEDICAL INTERNATIONAL LTD. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC —, cap $294.2M) and INGN (Inogen Inc) posts a D- grade (36/100 RQD, P/E 8.5x, ROIC -27.0%, cap $192.7M). Among the 5-stock peer group, SMTI leads on earnings multiple (8.1x) while SMTI leads on capital efficiency (16.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for SMTI?

▼

Per SMTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000714256), Sanara MedTech Inc. generated $103.1M in revenue (+19.0% YoY), $37.6M in net income, and $2.2M in free cash flow against $72.9M in total assets and $46.0M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $32.86 (-0.17%)🧬 Cannibal Buyback (-0.60% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 2.1% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 55/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.5% avg 90D alpha vs SPY • 51.4% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-1.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for SMTI)Realized 20D OHLCV Swing Band: ±3.9%

Deterministic 5-Pillar Attribution (55/100 Composite)

🔍 WHY SMTI SCORES 55/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+14/20 pts (25% of score)

Altman Z-Score 3.25 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+14/20 pts (25% of score)

SEC Form 4 / 13F Thermometer: 70% Net Buy • Cannibal Buyback (-0.60% YoY Shares)

▼ #1 Drag / Risk Factor: Macro Regime Fit9/20 pts (-11 pt drag)

Macro rate sensitivity & RSI-14 (30.4) create a -11 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$35.15-5.7% Next Q

Q2 (-2Q)

Grade C$33.14-0.4% Next Q

Q3 (-1Q)

Grade C$33.02-0.3% Next Q

Current

Grade D+$32.92-0.5% Hist 90D α

Trajectory: C+ (63) → D+ (55)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the SMTI Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 55/100 (D+) score, SMTI faces multiple-compression risk if 8.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-0.60% YoY Shares) — any gross margin slip below 90.2% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($34.48) or 200D SMA ($25.53) invalidates the momentum regime and cuts Target Base ($32.48) toward Bear Floor ($25.33).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $SMTI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “SMTI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 55%NO 45%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±3.9%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (SMTI)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for SMTI.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring SMTI)

✓Walkthrough of SMTI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

SMTI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +73.35%🛡️ HOLDING TREND SUPPORT

2026-11-02O $32.88H $32.92L $32.88C $32.92VOL 35.1K

RES: $36.18SUP: $31.76SMA50: $34.48SMA200: $25.53

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SMTI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SMTI Butterfly Map → + Track SMTI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

-5.2%/yr Implied 5Y Growth

vs. +19.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SMTI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SMTI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SMTI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (SMTI)

Health Care Rank #232 of 1016 ⚔️ ZJYL vs SMTI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (SMTI vs. ZJYL, INGN, AVR, AGPU)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Sanara MedTech Inc. (SMTI) ranks #232 by composite RQD confidence (55/100, grade D+) and #518 by equity capitalization ($302.4M). Within this direct 5-issuer industry benchmark cohort, SMTI leads on earnings valuation at 8.1x trailing P/E, while SMTI leads on capital efficiency and profitability with 16.3% ROIC and 92.7% gross margin. SMTI currently leads its immediate peer cohort in composite quantitative strength at 55/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
SMTI ACTIVE Sanara MedTech Inc.	D+	55/100	8.1x	92.7%	16.3%	+0.11%	$302.4M	Benchmark Subject
ZJYL JIN MEDICAL INTERNATIONAL LTD. (Class A)	D-	36/100	—	29.2%	—	-2.10%	$294.2M	/zjyl-vs-smti →
INGN Inogen Inc	D-	36/100	8.5x	52.2%	-27.0%	+0.14%	$192.7M	/ingn-vs-smti →
AVR Anteris Technologies Global Corp.	E	23/100	—	70.3%	-35.0%	+5.25%	$625.9M	/avr-vs-smti →
AGPU Axe Compute Inc.	D	44/100	—	—	-35.0%	-2.01%	$101.7M	/agpu-vs-smti →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000714256

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Sanara MedTech Inc. (SMTI) reported GAAP revenue of $103.1M (+19.0% vs. FY2024 revenue of $86.7M , and +58.7% cumulative change since FY2023) , GAAP net income of $37.6M, operating cash flow of $6.8M, and free cash flow of $2.2M (+1041.1% YoY). On the balance sheet, SMTI closed FY2025 with $72.9M in total assets against $46.0M in total debt (Altman Z-Score: 3.25, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$103.1M	$37.6M	$6.8M	$2.2M	$72.9M	$46.0M
FY2024 (FY)	2024-12-31	$86.7M	$9.7M	-$23.8K	-$229.6K	$88.1M	$30.7M
FY2023 (FY)	2023-12-31	$65.0M	$4.3M	-$3.2M	-$3.2M	—	—

3. SMTI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is SMTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does SMTI compare to ZJYL and INGN in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for SMTI?

Where is SMTI trading relative to its 50-day, 200-day, and 52-week technical levels?

SMTI last traded at $32.92 (+0.11% on volume of 35,140 shares), positioning the stock -4.52% below its 50-day simple moving average ($34.48) and +28.95% above its 200-day simple moving average ($25.53). Across its 52-week range of $16.05 to $35.52, SMTI sits at the 86.6% percentile with a 14-day RSI of 30.4 (OVERSOLD (<32)) and an implied next-earnings move of ±3.9% ($31.64 to $34.20).

SMTI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is SMTI's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for SMTI.

Direct Sub-Reports: SMTI RQD Cockpit SMTI 12M Forecast SMTI Earnings & Move SMTI Dividends & DRIP SMTI Insiders & 13F SMTI Whale Options SMTI Profit Sankey SMTI News & Why